ARCHIVES

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

This article is from The Cancer Letter archive.

Vol. 40 No. 45 | December 5, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Schmidt Sells OMB On Training Grants, But Weinberger Is The One To Convince

December 21, 1973

Tom Curran Becomes AACR President, Hong Is President-Elect; Attendance 13,000.

April 14, 2000

Raise Cigarette Taxes, Fully Fund Bypass Budget, Increase Biomedical research Support, NCAB Urges

October 6, 1989

FDA, NCI Seek Compromise On Survival Endpoints

June 16, 1989

CMS Looks At Coverage of Two Agents Approved on Surrogate Endpoints

February 21, 2003

Guidelines Working Group Agrees On 4750,00 As Base; Steckel Says AACI May Object To “Freeze” On Core

November 21, 1980